ELRN making a big splash with all the companies they own. Many of these companies are young growth companies with great products.

Market Cap 209.3 M at $7.00 a share and they will be receiving between $180 Mil to $213 Mil for the sell. At this sale would double the share price. Plus other companies sales are showing positive future sales in the coming quarters.

Medingo is 92% held by Elron (including 83% held by RDC, Elron's 50.1% subsidiary). Medingo is engaged in the development and commercialization of a miniature insulin dispensing patch pump for the needs of insulin-dependent diabetic patients.